Clinical Trial: Study of the Safety of Intravenous Artesunate

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Phase 1 Double-Blind, Placebo-Controlled, Randomized Multiple Dose Escalation Study to Evaluate the Safety, Tolerance, and Pharmacokinetics/Pharmacodynamics of a New GMP Formulation of Intravenous A

Brief Summary: The purpose of this study is to establish the safety, tolerability, and pharmacokinetics of a multiple dose of the antimalarial drug artesunate.

Detailed Summary:
Sponsor: U.S. Army Medical Research and Materiel Command

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: U.S. Army Medical Research and Materiel Command

Dates:
Date Received: February 14, 2006
Date Started:
Date Completion:
Last Updated: October 25, 2016
Last Verified: March 2007